Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America-Reference-Cited by-同舟云学术

Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America

Published:2018-12 Issue: Volume:77 Page:82-86
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Sader Helio S.,Flamm Robert K.,Streit Jennifer M.,Carvalhaes Cecilia G.,Mendes Rodrigo E.

Funder

Pfizer

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference15 articles.

1. M07Ed11E. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard;CLSI,2018

2. M100Ed28E. Performance standards for antimicrobial susceptibility testing: 28th informational supplement;CLSI,2018

3. Breakpoint tables for interpretation of MIC’s and zone diameters. Version 8.0, January 2018;EUCAST,2018

4. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia;File;Clin Infect Dis,2010

5. Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia;Frampton;Drugs,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro activity of ceftaroline against bacterial isolates causing skin and soft tissue and respiratory tract infections collected in Latin American countries, ATLAS program 2016–2020;Journal of Global Antimicrobial Resistance;2024-03

2. In vitro Activity of Ceftaroline Against Isolates of Gram-Positive Bacteria from Patients with Bloodstream Infections Collected as a Part of ATLAS Between 2017 and 2020;Infection and Drug Resistance;2024-01

3. Evaluation of in vitro activity of ceftaroline against pathogens associated with community-acquired pneumonia: ATLAS program 2017–2019;Journal of Global Antimicrobial Resistance;2023-06

4. Population pharmacokinetic/pharmacodynamic study suggests continuous infusion of ceftaroline daily dose in ventilated critical care patients with early-onset pneumonia and augmented renal clearance;Journal of Antimicrobial Chemotherapy;2022-09-05

5. Efficacy of Doxycycline for Mild-to-Moderate Community-Acquired Pneumonia in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Clinical Infectious Diseases;2022-07-29